{
    "nctId": "NCT02592213",
    "briefTitle": "Treatment of Breast Cancer Related Lymphedema With Cell-assisted Lipotransfer",
    "officialTitle": "Treatment of Breast Cancer Related Lymphedema With Cell-assisted Lipotransfer",
    "overallStatus": "UNKNOWN",
    "conditions": "Lymphedema",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1, PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 10,
    "primaryOutcomeMeasure": "Change in arm volume",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Unilateral arm lymphedema secondary to breast cancer treatment including lymph node dissection.\n2. The patient understands the nature and purpose of this study and the study procedures and has signed informed consent.\n3. The opposite upper extremity is healthy.\n4. ASA score of 1 or 2.\n5. The patient is able to read, understand, and complete Danish questionnaires.\n6. Lymphedema grade 1 or 2. A minimum circumference distance of 2cm on either lower or upper arm.\n\nExclusion Criteria:\n\n1. The patient is pregnant or lactating.\n2. The patient has bilateral lymphedema of the upper extremities.\n3. The patient has or has had other malignancies other than breast cancer.\n4. The patient is treated with anti-diabetic medication.\n5. The patient is diagnosed with any form of psychotic disorder.\n6. The patient is smoking.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}